Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2020-08-04 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1356 characters) and begins with 'RNS Number : 1155V', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading mechanisms, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate fallback category is Regulatory Filings (RNS).
2020-08-04 English
Collaboration to automate COVID-19 PCR testing
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's Regulatory Information Service (RNS). The content describes a collaboration between Genedrive plc and Beckman Coulter Life Sciences regarding COVID-19 PCR testing automation. This type of announcement, detailing a significant business development or partnership, is typically classified as a general regulatory filing or news release that doesn't fit into the more specific categories like 10-K, ER, or DIV. Since it is a formal announcement distributed through the RNS system and doesn't fit the criteria for RPA (it is the news itself, not just an announcement *about* a report), the most appropriate classification is the general regulatory filing category, RNS.
2020-08-04 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1371 characters) and begins with 'RNS Number : 9024T', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational notice rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action announcement (like DIV or ER). Since it is a general regulatory announcement that doesn't fit the highly specific categories (AGM-R, 10-K, CT, DIRS, etc.), the most appropriate fallback category is Regulatory Filings (RNS).
2020-07-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1354 characters) and begins with 'RNS Number : 9014T', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Price Monitoring Extension' for an auction call period, which is a procedural update related to trading mechanics, not a core financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or MANG, the most appropriate classification is the general regulatory filing fallback category.
2020-07-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly starts with "RNS Number : 7983T" and contains standardized tables for reporting changes in major shareholdings, specifically referencing "TR-1: Standard form for notification of major holdings". This form is used to report when a person's holding in a company's voting rights crosses a regulatory threshold. This type of mandatory disclosure falls under regulatory reporting concerning share ownership changes. The closest specific category is Major Shareholding Notification (MRQ). Although RNS is present in the header, MRQ is a more precise classification for a TR-1 filing than the general Regulatory Filings (RNS) fallback.
2020-07-22 English
Second Price Monitoring Extn
Share Issue/Capital Change Classification · 1% confidence The document is very short (1371 characters) and begins with 'RNS Number : 6352T', indicating it is a regulatory news service announcement from the London Stock Exchange. The content discusses a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls. Since this is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), and it is an announcement rather than a full report, the most appropriate classification is the general regulatory filing fallback category, RNS.
2020-07-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.